An electricity independent, low cost, neonatal Continuous Positive Airway Pressure device
Each year more than 1.2 lakh children with respiratory distress die during transportation to health care centers. The high mortality rates can be prevented with the application of Continuous Positive Airway Pressure (CPAP), but unfortunately, these CPAP devices are bulky, require skilled manpower and are only available at Neonatal Intensive Care Units (NICU). This gap was recognized by innovators Nitesh, Nachiket and Basava of COEO Labs, and the trio came up with a neonatal breathing support device called SAANS, an electricity independent, low cost, multimodal, neonatal CPAP device to maintain oxygenation and respiration during transport to the NICU at a tertiary health care center. At present, the SAANS concept has been demonstrated to health care providers in over 56 rural hospitals in Karnataka and the team is close to launching the device in the market.